This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Monica Mann: Innovator in Cancer Therapy
Introduction
Monica Mann is a prominent inventor based in Austin, TX (US). She has made significant contributions to the field of cancer therapy through her innovative research and patents. Her work focuses on the targeting of PELP1, a protein involved in oncogenic signaling in cancers.
Latest Patents
Monica Mann holds a patent titled "Targeting of PELP1 in cancer therapy." This patent describes PELP1 binding peptides and peptoids, which are utilized to interact with molecules that lead to oncogenic signaling in various cancers. Her innovative approach aims to enhance cancer treatment options and improve patient outcomes.
Career Highlights
Monica is affiliated with the University of Texas System, where she conducts her research. Her dedication to advancing cancer therapy has positioned her as a key figure in her field. With a focus on practical applications of her research, she continues to explore new avenues for therapeutic interventions.
Collaborations
Monica has collaborated with notable colleagues, including Ratna K Vadlamudi and Samaya Krishnan. These partnerships have enriched her research and contributed to the development of innovative solutions in cancer therapy.
Conclusion
Monica Mann's work exemplifies the impact of innovation in the medical field, particularly in cancer therapy. Her contributions through her patent and collaborations highlight the importance of research in developing effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile